Updates &
Announcements
June 16, 2021
Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe
Life sciences is poised to be Boston’s dominant industry. Has the area become the Silicon Valley of biotech? – The Boston Globe
June 4, 2021
Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage
Biopharma and Venture Capital: A Deep Dive – Evaluate Vantage
May 4, 2021
Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021
Omega Funds’ Otello Stampacchia Participates in BIO Deutschland’s German Corona Showcase 2021
April 28, 2021
Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
April 26, 2021
Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast
Omega’s Michelle Doig joins RBC Capital Markets’ Pathfinders in Biopharma podcast
February 12, 2021
2021: The Rise of the Variants – TimmermanReport.com
2021: The Rise of the Variants – TimmermanReport.com
January 14, 2021
Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal
Biotech Startup Acquisitions Jumped in 2020, Leaving VCs Optimistic for New Year – Wall Street Journal
January 7, 2021
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
January 7, 2021
LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies
LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies
January 7, 2021
Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease
Endeavor BioMedicines Launches with $62 Million Series A Financing and Mission to Reverse the Course of Devastating Pulmonary Disease
